June 01, 2022
Zydus Pharmaceuticals USA Inc. shed claims by 209 people alleging they or their loved ones were harmed by the off-label marketing of a generic heart medication, with a New Jersey federal judge rejecting arguments that the company had a duty to warn prescribing physicians about the drug's dangers.